The hazard ratio (HR) was statistically significant in HR+HER2+ (HR = 1.18, p < 0.001) and HR+HER2-, demonstrating that the ECMI is a reliable risk factor in BC when both hormone receptor and HER2 are positive. Here, ERBB2 is linked to breast cancer.